Ok, here's my take on the 25 million shares. The shares

New Post Public Reply Private Reply Replies (2) Message Board
adirondackhi
826
Ok, here's my take on the 25 million shares. The shares that were returned, even if only for 6 months, were common shares, not preferred shares, and therefore cannot be "converted" into any more common shares.

Even if the shares were all sold in the next quarter, it wouldn't have much of an impact unless they "dumped" the shares, meaning they sold all of them at once as sell @ market sales which could cause a temporary dip in the pps. I know those dudes aren't going to do that. They are fully aware of the long term value of those shares, and they only locked them up temporarily to show that they weren't planning on dumping and running on the next couple of big PR's. This is real, and they're in for the long haul.

In six months, the pps will not be parked here. It will have moved up again and drawn more investment interest than at any point in it's history. The guys would be even more crazy to liquidate all of their shares at that point since the future growth of the company will be even more readily apparent.

My point really, however, was that even if they sold their 25 mil shares (again, not), it would only be about 2.5% of the outstanding shares. I repeat, it's highly unlikely that all of them would actually dump those shares at the same time, in their entirety, when in merely six more months from becoming unrestricted again they could easily be worth several times as much and I firmly believe they WILL be. I'm thoroughly convinced that they believe the same thing. Just wouldn't make sense as it's obvious at this point we're not looking at a P & D scam.

Anyone who expresses as much doubt as I see in some posts right now is either working with a hidden agenda (phony, trying to move the pps lower) or just shouldn't be investing in OTC start-up companies. If they can't see the value of the investment for where it's going and not based on overwhelming financials (like you do with big board high priced stocks), then why are they still here?????

Shouldn't they have moved on by now???? Ask yourself that and really think about it. If you really thought so negatively about the outlook as a whole, wouldn't you sell and move on? If you were in the red and desperate to get back in the green, whether or not you intended to get out when you're green again, wouldn't you want to pump the stock instead of speaking negatively about it which is more likely to cause people to sell their shares and drag the pps down????

If the argument is that these things need to be addressed, wouldn't it be smarter to do so in private with direct communications to management/directors as opposed to on a public forum where your greatest possible accomplishment would be to hurt the value of your investment??? These are the questions I ask myself when trying to determine the integrity and/or sensibility in posts. Trends and similarities are easy to spot after awhile.

Some who flip stock on a regular basis are very good at the use of manipulation to impact the price. Even with large companies as the crooked short sales pro Whitney Tilson so slyly demonstrated when he smacked down Lumber Liquidators. When I closely poured over the evidence (not the headlines) in that case, I realized the ONLY thing they were actually guilty of other than sloppy management was their violation of the Lacy Act, by importing a protected hardwood from Russia.

The formaldehyde allegations were as phony as it gets, but LL chose to remain humbly quiet, allowing the courts to put it to rest rather than make a circus of it by feeding the press with the drama they lust for. They were already down, their sales had been sorely impacted, so letting the BS fade away rather than keeping it alive in the press was their smartest move since the courts move slowly and you need irrefutable proof behind you if you want to make it a full on brawl in full view of the public. Especially since most consumers (not so much investors) won't analyze the evidence for themselves much deeper than the headlines which would, again, be laced with bias to "help" the drama along. That's what butters their bread.

Anderson Cooper of CNN played a major part in that BS fiasco, and he's been involved in investigations for phony news reporting more than once in the past. In summary, there are a lot of phony f#*!s out there, big and small.

We have not seen as much as a scrap of evidence to suggest that this company's management/directors have been phony or crooked in any way, ever, with one exception which makes the integrity of the company as a whole obvious: Tom Shuman did some closet moonlighting, and as soon as Jerry became aware of it, Shuman was gone and agreed to give back 30 million shares of stock to the treasury. I think we're in great hands at this point, and we're going to make more money on the investment than many dare to hope if we just ignore the BS and hold on to our shares.

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurotrope, Inc. Achieves New Milestone with Stock Surge

Updated Category News Views 147

Neurotrope, Inc. Reaches New Stock Milestone Neurotrope, Inc. (NASDAQ: NTRP) has recently achieved a significant milestone in the stock market, soaring to a 52-week high with its price reaching $7.00. This impressive climb indicates a remarkable 124.95% increase over the past year, showcasing strong investor interest and confidence in the company's future prospects. The...

Continue Reading
Lil Nas X's Legal Challenges and Public Struggles Unfold

Updated Category News Views 284

Lil Nas X Pleads Not Guilty to Serious Charges Grammy-winning musician Lil Nas X has recently made headlines for pleading not guilty to multiple felony charges stemming from an incident involving police officers. This situation arose when he was found walking unclothed on the streets of Los Angeles. Understanding the Legal Battle Ahead The rapper, known legally as Montero...

Continue Reading
Exyte's Strategic Acquisition of TTP Group Enhanced Operations

Updated Category News Views 51

Exyte Acquires TTP Group to Strengthen Engineering Expertise Exyte, a leader in high-tech facility engineering, has officially completed the acquisition of TTP Group, enhancing its operations and expertise especially in the biopharma and life sciences sectors. This acquisition marks a significant milestone for Exyte as it melds TTP's capabilities with its own, aiming to...

Continue Reading
Unveiling Health Innovations: Zepp Health at CES 2024 Events

Updated Category News Views 372

Zepp Health Showcases Innovative Technologies at CES Zepp Health Corporation (NYSE: ZEPP), a leader in health technology and smart wearables, is excited to announce its participation in significant media events like Pepcom and ShowStoppers at CES. These occasions will showcase Zepp Health's latest advancements in smart wearables and health technologies, aimed at...

Continue Reading
Meridian Locks $186M Loan for NJ Condo Project

Updated Category News Views 163

New Jersey's Coastline Gets a $186 Million Facelift Here's a move that'll shake the Jersey Shore awake: Meridian Capital Group's just put their money where the sand is with a massive $186 million scoop for a new high-end condominium project in Asbury Park. You couldn't make up a better setting—a beachfront spot ripe for some high-end living. But let's not get too...

Continue Reading